Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases July 30, 2020 Lineage Cell Therapeutics to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020 July 06, 2020 Lineage Cell Therapeutics Announces Extension of OpRegen® Development Grant From Israel Innovation Authority June 25, 2020 Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for Spinal Cord Injury VIEW PRESS RELEASES Events & Presentations Second Quarter 2020 Financial Results Earnings Call Aug 6, 2020 at 5:30 PM EDT Lineage Cell Therapeutics at 2020 Raymond James Human Health Innovation Conference Jun 18, 2020 at 9:40 AM EDT Therapeutic Experts Call: OpRegen® - A Discussion of Retinal Tissue Regeneration in Dry-AMD with Geographic Atrophy Jun 8, 2020 at 4:30 PM EDT VIEW EVENTS & PRESENTATIONS
July 30, 2020 Lineage Cell Therapeutics to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
July 06, 2020 Lineage Cell Therapeutics Announces Extension of OpRegen® Development Grant From Israel Innovation Authority
June 25, 2020 Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for Spinal Cord Injury
Lineage Cell Therapeutics at 2020 Raymond James Human Health Innovation Conference Jun 18, 2020 at 9:40 AM EDT
Therapeutic Experts Call: OpRegen® - A Discussion of Retinal Tissue Regeneration in Dry-AMD with Geographic Atrophy Jun 8, 2020 at 4:30 PM EDT
